Brief: Venus Remedies Launches Its Flagship Research And Development Drug Elores In Oman
17/08/2023 07:33
Aug 17 (Reuters) - Venus Remedies Ltd VENR.NS :
* LAUNCHES ITS FLAGSHIP RESEARCH AND DEVELOPMENT DRUG ELORES
IN
OMAN
Source text for Eikon: ID:nBSE4pLRlW
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage